Technical Analysis for NEO - NeoGenomics, Inc.

Grade Last Price % Change Price Change
F 14.55 -0.95% -0.14
NEO closed down 0.95 percent on Monday, March 18, 2024, on 53 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Gapped Down Weakness -0.95%
Oversold Stochastic Weakness -0.95%
MACD Bearish Centerline Cross Bearish -1.22%
Gapped Down Weakness -1.22%
Oversold Stochastic Weakness -1.22%
20 DMA Resistance Bearish -5.95%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Fell Below Lower Bollinger Band about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 2 % about 20 hours ago
Down 1% about 20 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeoGenomics, Inc. Description

NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company's trademarks include NeoFISH, NeoFlow, NeoSITE, NeoArray, NeoType, and MelanoSITE. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Disease Telehealth Telemedicine Lymphoma Genetics Genomics Medical Test Lab Testing Leukemia Bladder Cancer Solid Tumor Cancers Flow Cytometry Laboratory Techniques Anatomical Pathology Hybridization Cytogenetics

Is NEO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.22
52 Week Low 11.045
Average Volume 978,865
200-Day Moving Average 15.69
50-Day Moving Average 15.44
20-Day Moving Average 15.70
10-Day Moving Average 15.39
Average True Range 0.68
RSI (14) 39.39
ADX 17.34
+DI 13.83
-DI 23.80
Chandelier Exit (Long, 3 ATRs) 15.45
Chandelier Exit (Short, 3 ATRs) 16.05
Upper Bollinger Bands 16.94
Lower Bollinger Band 14.46
Percent B (%b) 0.04
BandWidth 15.80
MACD Line -0.18
MACD Signal Line -0.04
MACD Histogram -0.1386
Fundamentals Value
Market Cap 1.85 Billion
Num Shares 127 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -18.90
Price-to-Sales 3.22
Price-to-Book 1.93
PEG Ratio 3.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.31
Resistance 3 (R3) 15.31 15.06 15.18
Resistance 2 (R2) 15.06 14.86 15.06 15.14
Resistance 1 (R1) 14.80 14.74 14.68 14.80 15.10
Pivot Point 14.55 14.55 14.49 14.55 14.55
Support 1 (S1) 14.30 14.36 14.17 14.30 14.00
Support 2 (S2) 14.05 14.24 14.05 13.96
Support 3 (S3) 13.79 14.05 13.92
Support 4 (S4) 13.79